Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 642 publications
Correction: ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.
Journal: Annals of surgical oncology
Published: September 05, 2026
Correction: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.
Journal: Annals of surgical oncology
Published: September 04, 2026
Circulating tumor DNA concentration at diagnosis is a modifiable prognostic factor for distant metastatic recurrence in patients with high-risk breast cancer receiving neoadjuvant therapy.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2026
ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.
Journal: Annals of surgical oncology
Published: July 31, 2026
ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.
Journal: Annals of surgical oncology
Published: July 31, 2026
TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10.
Journal: Future oncology (London, England)
Published: July 31, 2026
Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk ERBB2-Negative Breast Cancer: The I-SPY2 Randomized Clinical Trial.
Journal: JAMA oncology
Published: July 30, 2026
Netupitant versus aprepitant: model-predicted neurokinin-1 receptor occupancy and implications for long-delayed nausea and vomiting prevention.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 22, 2026
Correction: Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.
Journal: Cardio-oncology (London, England)
Published: July 10, 2026
Baseline gene expression and dynamic endocrine therapy use in ER+ breast cancer: associations with recurrence in a real-world cohort.
Journal: Research square
Published: July 10, 2026
Multi-state modeling associates proliferation genes with early estrogen receptor-positive breast cancer recurrence and survival.
Journal: Research square
Published: July 10, 2026
Response to correspondence received on "New perspectives on endocrine therapy suitability for hormone receptor-positive metastatic breast cancer in clinical practice".
Journal: Breast (Edinburgh, Scotland)
Published: July 10, 2026
Last Updated: 09/26/2026